Wellington Management Group’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
Other funds holding ARCT
AIM
NAMA
Wellington Management Group's ARCT Position: Q4 2025 in Review
Wellington Management Group sold out of Arcturus Therapeutics (ARCT) in Q4 2025, closing a stake of 85,483 shares — an estimated $1.58M sold.
Wellington Management Group first reported a position in ARCT in Q4 2021 and held it in 16 quarters. The position peaked at $9.63M in Q1 2024. 120 funds tracked by Wall St. Rank hold ARCT as of Q4 2025.
- Wellington Management Group reported no remaining Arcturus Therapeutics position as of Q4 2025 after selling out during the quarter.
- Wellington Management Group sold 85,483 Arcturus Therapeutics shares in Q4 2025, an estimated $1.58M.
- Wellington Management Group first reported a position in Arcturus Therapeutics in Q4 2021 and held it in 16 quarters.
- Wellington Management Group's Arcturus Therapeutics position peaked at $9.63M in Q1 2024.
- 120 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q4 2025.
Based on Wellington Management Group's 13F filing for Q4 2025, filed 17 Feb 2026.